血清视黄醇结合蛋白4对非酒精性脂肪性肝炎的诊断价值

doi:10.3969/j.issn.1672-5069.2011.05.013

实用肝脏病杂志 ›› 2011, Vol. 14 ›› Issue (5): 351-353.doi: 10.3969/j.issn.1672-5069.2011.05.013

血清视黄醇结合蛋白4对非酒精性脂肪性肝炎的诊断价值

李丽,闵若谦,展玉涛,赵淑杰

100123 北京市民航总医院体检康复中心（李丽，闵若谦，赵淑杰）；首都医科大学附属北京同仁医院消化内科（展玉涛）

收稿日期:2011-05-20 出版日期:2011-10-15 发布日期:2016-04-14
作者简介:李丽女，27岁，医学硕士，医师。主要从事慢性肝病及肝纤维化的诊治研究。E-mail:dadi-121@163.com

Significance of serum retinol-binding protein 4 in the diagnosis of patients with nonalcoholic steatohepatitis

LI Li，MIN Ruoqian，ZHAN Yutao，et al.

Center for Physical Examination and Rehabilitation，Civil Aviation General Hospital，Beijing 100123，China

Received:2011-05-20 Online:2011-10-15 Published:2016-04-14

摘要/Abstract

摘要： 目的探讨血清视黄醇结合蛋白4（RBP4）对非酒精性脂肪性肝炎（NASH）的临床诊断价值。方法选择经肝活检证实的NASH（42例）、单纯性脂肪肝（28例）和健康体检者（20例），采用ELISA法检测血清RBP4水平。以肝组织病理学检查结果为金标准，应用受试者工作特征曲线（ROC）评价血清RBP4对NASH的诊断价值。结果 NASH患者血清RBP4水平为37.11±7.68mg/L，明显高于单纯性脂肪肝患者（22.83±6.33mg/L，P<0.01）和对照人群（19.38±5.46mg/L，P<0.01）；RBP4诊断NASH的AUC为0.804，灵敏度和特异度分别为79.6%和76.6%。结论 NASH患者血清RBP4水平明显升高，可作为诊断NASH的敏感指标之一。

关键词: 非酒精性脂肪性肝炎, 血清视黄醇结合蛋白4, 诊断

Abstract: Objective To evaluate the clinical significance of serum retinol-binding protein 4（RBP4）in the diagnosis of patients with nonalcoholic steatohepatitis（NASH）. Methods Serum RBP4 was measured in triplicates by a specific enzyme-linked immunosorbent assay in 42 biopsy-proven patients with NASH，28 with fatty liver and 20 healthy people. The diagnostic performance of the serum RBP4 was assessed by analysis of receiver operating characteristic（ROC）curve. Results Serum RBP4 level in the NASH was 37.11±7.68mg/L，significantly higher than that in the simple steatosis cases（22.83±6.33mg/L，P<0.01）or in control subjects（19.38±5.46mg/L，P<0.01）；The area under the curve for serum RBP4 were 0.804 and the sensitivity and specificity for diagnosis of NASH were 79.6%和76.6%，respectively. Conclusion This study demonstrates that serum RBP4 levels may be a sensitive marker to detect patients with NASH.

Key words: Nonalcoholic steatohepatitis, Retinol-binding protein 4, Diagnosis

李丽,闵若谦,展玉涛,赵淑杰. 血清视黄醇结合蛋白4对非酒精性脂肪性肝炎的诊断价值[J]. 实用肝脏病杂志, 2011, 14(5): 351-353.

LI Li，MIN Ruoqian，ZHAN Yutao，et al.. Significance of serum retinol-binding protein 4 in the diagnosis of patients with nonalcoholic steatohepatitis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2011, 14(5): 351-353.

参考文献

[1] PETTA S，TRIPODOB C，GRIMAUDO S，et al. High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis[J]. Dig Liver Dis，2011（43）:404-410.
[2] PETTA S，CAMMA C，DI MARCO V，et al. Retinol-binding protein 4:A new marker of virus-induced steatosis in patients infected with hepatitis C virus genotype 1[J]. Hepatology，2008，48（1）:28-37.
[3] 杨紧根. 肝病患者血清视黄醇结合蛋白的检测及意义[J]. 中国医师杂志，2009，11 （7）：965-966.
[4] YAN K K，PALMER C S，LLOYD A R，et al. Relationship of retinol-binding protein 4 with liver injury in morbidly obese subjects[J]. Hepatology，2009，50 （4）:S789A.
[5] GRAHAM TE，YANG Q，BLUHER M，et al. Retinol-binding protein 4 and insulin resistance in lean，obese，and diabetic subjects[J]. N Engl J Med，2006，354（22）:2552-2563.
[6] KAWAGUCHI R，YU J，WIITA P，et al. An essential ligand-binding domain in the membrane receptor for retinol-binding protein revealed by large-scale mutagenesis and a human polymorphism[J]. Biol Chem，2008，283（22）:15160-15168.
[7] MIURA N，KITAMURA H，KAMEKO M. Evaluation of the reference range of retinol-binding protein（RBP）levels by the latex turbidimetric immunoassay[J]. Rinsho Byori，2009，57（3）:195-199.
[8] SEO JA，KIM NH，PARK SY，et al. Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease[J]. Clin Endocrinol（Oxf），2008，68（4）:555-560.
[9] N0BILI V，ALKHOURI N，ALISI A，et al. Retinol-binding protein 4:a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease[J]. Clin Gastroenterol Hepatol，2009，7（5）:575-579.
[10] FERRE P. The biology of peroxisome proliferator-activated receptors:relationship with lipid metabolism and insulin sensitivity[J]. Diabetes，2004，53 （Suppl.1）:S43-S50.
[11] YANG Q，GRAHAM TE，MODY N. Serum retinol-binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes[J]. Nature，2005，436（7049）:356-362.

[1]	中国研究型医院学会肝病专业委员会, 中国医师协会脂肪性肝病专家委员会. 脂肪性肝病诊疗规范化的专家建议（2019年修订版）[J]. 实用肝脏病杂志, 2019, 22(6): 787-792.
[2]	. 肝纤维化诊断及治疗共识（2019年）[J]. 实用肝脏病杂志, 2019, 22(6): 793-803.
[3]	吴海义, 陈建新. 四种诊断模型诊断乙型肝炎病毒携带者肝纤维化的效能分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 832-835.
[4]	曹策, 郁义星, 王贝贝, 赵卫峰. 增强磁共振成像联合血清甲胎蛋白和脱-γ-羧基凝血酶原诊断肝细胞癌临床价值探讨[J]. 实用肝脏病杂志, 2019, 22(6): 896-899.
[5]	曾艳妮, 张灿, 毕俊英, 刘良进, 孟俊, 秦涛. MRI长时间延迟增强扫描诊断肝脏孤立性坏死性结节价值研究^*[J]. 实用肝脏病杂志, 2019, 22(6): 900-903.
[6]	邢昊, 韩骏, 杨田. 应用血清PIVKA-II诊断肝细胞癌研究进展^*[J]. 实用肝脏病杂志, 2019, 22(6): 934-937.
[7]	梁巨波, 苗琪, 马雄. 胆管细胞型胆汁淤积诊治进展[J]. 实用肝脏病杂志, 2019, 22(6): 941-943.
[8]	高伟, 侯勇. 肝脏硬度值检测诊断慢性乙型肝炎患者肝组织纤维化的效能分析*[J]. 实用肝脏病杂志, 2019, 22(5): 652-655.
[9]	黄汉军, 鲁凤荣, 张灿. 基于Exchange血流动力学模型的MRI扫描参数诊断肝硬化临床价值分析*[J]. 实用肝脏病杂志, 2019, 22(5): 696-699.
[10]	洪佳, 吴晓宁, 尤红. 胆汁淤积性肝病的规范化诊断[J]. 实用肝脏病杂志, 2019, 22(5): 758-760.
[11]	程华, 鞠辉, 宋德顺, 李伟. 慢性乙型肝炎患者血清血管生成素样蛋白2和高尔基体蛋白73水平变化及其诊断显著肝纤维化的效能分析^*[J]. 实用肝脏病杂志, 2019, 22(4): 494-497.
[12]	余英芳, 温生宝. 应用磁共振DWI单指数、双指数和拉伸指数模型参数评估慢性乙型肝炎患者肝纤维化程度效能研究^*[J]. 实用肝脏病杂志, 2019, 22(4): 502-505.
[13]	张亚飞, 叶珺, 谢琴秀, 邹桂舟, 李家斌, 李旭, 张振华. 不同医院无创性肝纤维化指标预测慢性乙型肝炎患者肝纤维化效能差异分析^*[J]. 实用肝脏病杂志, 2019, 22(4): 510-513.
[14]	谢晓, 刘婷, 董志霞, 夏幼辰, 张启迪, 曲颖, 蔡晓波, 徐铭益, 陆伦根. FibroTouch检测肝脏受控衰减参数对肝脂肪变的诊断价值分析^*[J]. 实用肝脏病杂志, 2019, 22(4): 526-529.
[15]	张骏飞, 许何明, 宋海燕, 董静, 潘劲劲, 陈照林, 徐军, 陈从新, 刘波. 自身免疫性肝炎-原发性胆汁性胆管炎重叠综合征：巴黎标准诊断中国患者灵敏度低[J]. 实用肝脏病杂志, 2019, 22(4): 537-540.

血清视黄醇结合蛋白4对非酒精性脂肪性肝炎的诊断价值

Significance of serum retinol-binding protein 4 in the diagnosis of patients with nonalcoholic steatohepatitis

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价